| 12187721 |
Protein tyrosine phosphatase inhibitors |
James F. Blake, Mark Laurence Boys, Mark Joseph Chicarelli, Adam Cook, Mohamed S. A. Elsayed +6 more |
2025-01-07 |
|
| 11884664 |
Protein tyrosine phosphatase inhibitors |
James F. Blake, Mark Laurence Boys, Mark Joseph Chicarelli, Adam Cook, Mohamed S. A. Elsayed +7 more |
2024-01-30 |
|
| 11780835 |
Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases |
Shelley Allen, Patrick Barbour, Adam Cook, Joshua Ryan Dahlke, John Gaudino +3 more |
2023-10-10 |
|
| 11634417 |
Protein tyrosine phosphatase inhibitors |
James F. Blake, Mark Laurence Boys, Mark Joseph Chicarelli, Adam Cook, Mohamed S. A. Elsayed +7 more |
2023-04-25 |
|
| 11267812 |
KRAS G12C inhibitors |
John P. Fischer, Jay Bradford Fell, James F. Blake, Macedonio J. Mejia, Erik James Hicken +10 more |
2022-03-08 |
|
| 11247990 |
Bicyclic fused pyridine compounds as inhibitors of TAM kinases |
Shelley Allen, Mark Laurence Boys, Adam Cook, John Gaudino, Ellen Laird +4 more |
2022-02-15 |
|
| 11104676 |
Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases |
Shelley Allen, Patrick Barbour, Adam Cook, Joshua Ryan Dahlke, John Gaudino +3 more |
2021-08-31 |
|
| 11028093 |
4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors |
Shelley Allen, Mark Laurence Boys, Mark Joseph Chicarelli, Jay Bradford Fell, John P. Fischer +13 more |
2021-06-08 |
|
| 10730880 |
4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors |
Shelley Allen, Mark Laurence Boys, Mark Joseph Chicarelli, Jay Bradford Fell, John P. Fischer +13 more |
2020-08-04 |
|
| 10633381 |
KRas G12C inhibitors |
James F. Blake, Laurence E. Burgess, Mark Joseph Chicarelli, James Gail Christensen, Jay Bradford Fell +11 more |
2020-04-28 |
|
| 10189845 |
4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors |
Shelley Allen, Mark Laurence Boys, Mark Joseph Chicarelli, Jay Bradford Fell, John P. Fischer +13 more |
2019-01-29 |
$44,601,000 |
| 10125134 |
KRas G12C inhibitors |
James F. Blake, Laurence E. Burgess, Mark Joseph Chicarelli, James Gail Christensen, Jay Bradford Fell +11 more |
2018-11-13 |
|
| 9079890 |
Intermediates for the preparation of pyridin-2-yl-amino-1,2,4-thiadiazole derivatives |
Thomas D. Aicher, Steven A. Boyd, Mark Joseph Chicarelli, Kevin Ronald Condroski, Jay Bradford Fell +5 more |
2015-07-14 |
$14,749,000 |
| 8933077 |
Glucokinase activators |
Thomas D. Aicher, Wai-Man Lee, Mark Joseph Chicarelli, Steven A. Boyd, Kevin Ronald Condroski |
2015-01-13 |
$3,576,000 |
| 8883828 |
2-aminopyridine analogs as glucokinase activators |
Thomas D. Aicher, Steven A. Boyd, Mark Joseph Chicarelli, Kevin Ronald Condroski, Ajay Singh |
2014-11-11 |
$5,786,000 |
| 8853409 |
Pyridin-2yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus |
Thomas D. Aicher, Steven A. Boyd, Mark Joseph Chicarelli, Kevin Ronald Condroski, Jay Bradford Fell +5 more |
2014-10-07 |
$1,724,000 |
| 8754226 |
Piperidinyl-substituted lactams as GPR119 modulators |
Thomas D. Aicher, Josef R. Bencsik, Kevin Ronald Condroski, Jay Bradford Fell, John P. Fischer +5 more |
2014-06-17 |
$6,789,000 |
| 8476300 |
Selective estrogen receptor modulator for the treatment of osteoarthritis |
Jeffrey A. Dodge, Timothy Ivo Richardson, Christian Alexander Clarke, Scott Alan Jones, Conrad Wilson Hummel +1 more |
2013-07-02 |
$233,467,000 |
| 8431713 |
2-aminopyridine derivatives as glucokinase activators |
Thomas D. Aicher, Steven A. Boyd, Mark Joseph Chicarelli, Kevin Ronald Condroski, Rustam Ferdinand Garrey +2 more |
2013-04-30 |
$4,417,000 |
| 8362037 |
2-aminopyridine analogs as glucokinase activators |
Thomas D. Aicher, Steven A. Boyd, Mark Joseph Chicarelli, Kevin Ronald Condroski, Ajay Singh |
2013-01-29 |
$3,041,000 |
| 8354540 |
2-aminopyridine analogs as glucokinase activators |
Thomas D. Aicher, Steven A. Boyd, Mark Joseph Chicarelli, Kevin Ronald Condroski, Ajay Singh |
2013-01-15 |
$6,341,000 |
| 8217032 |
Selective estrogen receptor modulators for the treatment of vasomotor symptoms |
Robert Dally, Jeffrey A. Dodge, Scott Alan Frank, Timothy Alan Shepherd, Owen Brendan Wallace |
2012-07-10 |
$71,763,000 |
| 8212045 |
Pyridin-2-yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus |
Thomas D. Aicher, Steven A. Boyd, Mark Joseph Chicarelli, Kevin Ronald Condroski, Jay Bradford Fell +5 more |
2012-07-03 |
$1,496,000 |
| 8088776 |
Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
Thomas D. Aicher, Zhaogen Chen, Gary Alan Hite, Alexei Pavlovych Krasutsky, Renhua Li +8 more |
2012-01-03 |
$89,536,000 |
| 8022222 |
Glucokinase activators |
Thomas D. Aicher, Steven A. Boyd, Mark Joseph Chicarelli, Kevin Ronald Condroski, Rustam Ferdinand Garrey +2 more |
2011-09-20 |
$633,000 |
